Buy this article for $3.95

Have a coupon or promotional code? Enter it here:

When you buy this article you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.

Source:

Nursing2015

March 2012, Volume 42 Number 3 , p 16 - 16

Authors

Abstract

The FDA has alerted pharmacists and healthcare providers about potential confusion involving two medications with similar trade names: Durezol (difluprednate ophthalmic emulsion) and Durasal (salicylic acid). Durezol is an FDA-approved topical ophthalmic corticosteroid used to treat postoperative inflammation and pain associated with ocular surgery. Durasal, a topical preparation used to treat common and plantar warts, doesn't have FDA approval. One serious injury was reported when a pharmacist dispensed Durasal instead of Durezol to a patient following ocular surgery.The FDA screens medication proprietary names for similarities upon approval. However, because Durasal isn't FDA-approved, it evaded this safety check.The FDA has asked the manufacturer to remove Durasal from the marketplace. In the meantime, continue to scrutinize medication packages and labels and report any potential for confusion to MedWatch Safety Information and Adverse Event Reporting Program at www.fda.gov/MedWatch/report.htm

To continue reading, buy this article for just $3.95.

Have a coupon or promotional code? Enter it here: